期刊文献+

适利达治疗药物难控制性青光眼的疗效分析

适利达治疗药物难控制性青光眼的疗效分析
暂未订购
导出
摘要 目的分析用其它降眼压药物而眼压不能控制,增加适利达的疗效。方法48例患者虽用2种以上降眼压药物而眼压不能控制,增加0.005%适利达每晚一次,至少随访三个月。结果用两种抗青光眼药有18例(37.5%),用三种以上抗青光眼药30例(62.5%),其中有16例(33.3%)需口服乙酰唑胺片降眼压,加用0.005%适利达眼药水1周,1月,3月后,眼压由27.4mmHg降至16.5mmHg(P<0.001),16.4mmHg(P<0.001),16.1mmHg(P<0.001)。完全成功率为30例(62.5%),相对成功率为14例(29.2%),无效为4例(8.3%)。结论对已用降眼压药物而眼压不能控制的患者,增加适利达可以有效地控制眼压,防止青光眼对视功能的进一步损伤。 Objective Analysis the effect of additice latanoprost to maximum-tolerated medications with uncotroll glaucoma.Methods 48 cases has used two more kind of antiglaucoma,IOP was uncotrolled, add 0.005% latanoprost, once at night, at least follow up three month.Results 18cases(37.5%) used two different antiglaucoma medication, 30cases(62.5%)used three different antiglaucoma medication,16 cases(33.3%) need oral Diamox. Add 0.005% latanoprost for 1 week, 1 month, 3 month,the lOP was dicreased from 27.4mmHg to 16.5mmHg (P〈0.001), 16.4mmHg(P〈0.001), 16.1mmHg(P〈0.001).Comletely success was 30 cases(62.5%), relative success was 14 cases(29.2%), no effect was 4 cases(8.3%). Conclusion To additive latanoprost can effectively control IOP for maximumtolerated medications with uncotroll glaucoma.
作者 秦曦 吴栋
机构地区 延安市人民医院
出处 《当代医学》 2010年第10期149-150,共2页 Contemporary Medicine
关键词 适利达 青光眼 眼压 latarnoprost glaucoma intraocular pressure
  • 相关文献

参考文献9

  • 1Serle JB.Phamacological advances in the treatment of glaucoma[J].Drag&Aging,1994,5:156-170.
  • 2詹桂林.前列腺素治疗青光眼的最新进展[J].国外医学(眼科学分册),1997,21(3):129-133. 被引量:8
  • 3Racz P,Ruzsonyi MR,Nagy ZT,et al.Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue(PhXA41).An inhospital,placebo-controlled study[J].Arch Ophthalmol,1993,111:657-661.
  • 4Aim A,Widengard I,Kjellgren D,et al.Latanoprost administered once daily caused a maintained reduction of intrancular pressure in glaucoma patients treated concomitantly with timolol[J].Br J Ophthalmol,1995,79:12-16.
  • 5Watson PG.Latanoprost:two years experience of its use in the united kindom[J].Ophthalmology,1998,105:82-87.
  • 6Larsson LI.Mechanism of action of latanoprost[J].Asian J ophthalmol,1999,(3)suppl:6-7.
  • 7Tin Aung,FRCS,Hon T.Wang,et al.Comparison of the intraocular pressure--lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma[J].Ophthalmology,2000,107:1178-1183.
  • 8Camras CB,Aim A,Watson P,Stjernschantz J.Latanoprost,a pristaglandinanalog,for glaucoma treatment,Efficacy and safety after 1 year of treatment in 198 patients.The latanoprost study groups[J].Ophthalmoloty,1996,103:1916-1924.
  • 9Gamaras GB.Comparision of latamoprost and timolol in patients with ocular hypertension and glaucoma,a six-month masked multicenter trial in the united states.

二级参考文献2

  • 1Masayuki Nakajima,Yasumasa Goh,Ikuo Azuma,Osamu Hayaishi. Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans[J] 1991,Graefe’s Archive for Clinical and Experimental Ophthalmology(5):411~413
  • 2Giuseppe Giuffrè. The effects of prostaglandin F2α in the human eye[J] 1985,Graefe’s Archive for Clinical and Experimental Ophthalmology(3):139~141

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部